Both in Pharmaceuticals
Obsidian Therapeutics vs Alumis
Over the past year OBX returned −18.9% and ALMS returned −30.5%; their daily moves had a correlation of 0.44.
OBX −18.9% ALMS −30.5%Growth of $1, one year, split-adjusted
| Metric | OBX | ALMS |
|---|---|---|
| Price | $14.43 | $6.38 |
| Market cap | $891.4M | $825.8M |
| Today | −2.43% | −5.20% |
| 1 month | +6.2% | −6.9% |
| 6 months | — | −74.7% |
| Year to date | — | −34.6% |
| 1 year | — | +36.9% |
| Revenue growth (YoY) | — | −37.7% |
| Gross margin | — | 100.0% |
| Net margin | — | −8557.2% |
| P/E (TTM) | — | — |
| Price / sales | — | 111.6× |
| Net cash | — | $502.3M |
| Dividend yield | — | — |
| Volatility (60d) | — | 180.3% |
| Short % of float | 2.2% | 11.3% |
| Next earnings | — | — |
Shading marks the stronger figure where one clearly exists (lower is better for valuation and volatility).